Endurant Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Endurant Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-18,236	Closed	-$2.12M	–	74
2022 Q1	$2.12M	Buy	+18,236	New	+$2.13M	0.56%	37
2020 Q1	–	Sell	-21,361	Closed	-$1.27M	–	68
2019 Q4	$1.27M	Buy	+21,361	New	+$1.32M	0.4%	41
2019 Q3	–	Sell	-19,579	Closed	-$1.26M	–	59
2019 Q2	$1.26M	Buy	+19,579	New	+$1.26M	0.5%	41
2016 Q4	–	Sell	-9,481	Closed	-$726K	–	87
2016 Q3	$726K	Sell	9,481 -13,586	-59%	-$991K	0.27%	60
2016 Q2	$1.74M	Buy	23,067 +4,510	+24%	+$363K	0.58%	45
2016 Q1	$1.62M	Sell	18,557 -13,500	-42%	-$1.18M	0.52%	49
2015 Q4	$3.79M	Buy	32,057 +11,048	+53%	+$1.1M	1.27%	29
2015 Q3	$1.85M	Sell	21,009 -24,116	-53%	-$2.81M	0.62%	46
2015 Q2	$4.89M	Buy	45,125 +25,360	+128%	+$3.15M	1.44%	22
2015 Q1	$2.49M	Buy	+19,765	New	+$2.57M	0.82%	44

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Endurant Capital Management's TNDM Position: Q2 2022 in Review

Endurant Capital Management sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 18,236 shares — an estimated $2.12M sold.

Endurant Capital Management first reported a position in TNDM in Q1 2015 and held it in 10 quarters. The position peaked at $4.89M in Q2 2015. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

Endurant Capital Management reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
Endurant Capital Management sold 18,236 Tandem Diabetes Care shares in Q2 2022, an estimated $2.12M.
Endurant Capital Management first reported a position in Tandem Diabetes Care in Q1 2015 and held it in 10 quarters.
Endurant Capital Management's Tandem Diabetes Care position peaked at $4.89M in Q2 2015.
330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Endurant Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.